Skip to content
Hinge Bio
  • About Us
    • Overview
    • Management Team
    • Board of Directors
    • Scientific Advisory Board
  • Technology
    • Overview
    • Platform
  • Pipeline & Programs
    • Pipeline
    • Lead Program
  • News & Resources
    • Press Releases
    • Presentations & Publications
  • Contact Us
  • About Us
    • Overview
    • Management Team
    • Board of Directors
    • Scientific Advisory Board
  • Technology
    • Overview
    • Platform
  • Pipeline & Programs
    • Pipeline
    • Lead Program
  • News & Resources
    • Press Releases
    • Presentations & Publications
  • Contact Us

Anti-CD19/CD20 bispecific antibody with dual Fc domains mediates enhanced effector functions and durable depletion of memory B cells in vivo || Scientific Reports

September 4, 2025

Hinge Bio HB2198 Lupus SLE 2025 || Poster

May 23, 2025

Beyond Antibodies and CAR-T: Topologically Engineered, Superdimeric Antibody NK Engagers and T Cell Engagers for B Cell Depletion Demonstrating Cooperative Binding to Target and Effector Cells || Poster

November 16, 2024

American Association of Cancer Research (AACR) Annual Meeting 2024 || Poster

April 8, 2024

Topologically engineered antibodies and Fc-fusion proteins: a new class of multifunctional therapeutic candidates for SARS-CoV-2, cancer, and other disease || Presentation

March 23, 2022
hinge bio logo - white
  • Privacy
  • Terms of Use
  • Contact Us
  • Privacy
  • Terms of Use
  • Contact Us
  • Hinge Bio © 2026 All rights reserved
arrow to top